Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

24%

4 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (5)
P 1 (1)
P 2 (2)
P 3 (2)
P 4 (2)

Trial Status

Not Yet Recruiting8
Recruiting6
Completed2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07574294Completed

Dual REmission in Moderate-to-SEvere asthMa and Nasal Polyps

NCT07399665RecruitingPrimary

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

NCT06776042Not ApplicableRecruitingPrimary

Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery

NCT06338995Phase 3RecruitingPrimary

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

NCT07524127Not ApplicableNot Yet RecruitingPrimary

Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Polymorphonuclear Cells in the Middle Turbinate

NCT07436949Phase 1Not Yet RecruitingPrimary

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and Comorbid Asthma

NCT07313917Phase 2Not Yet RecruitingPrimary

A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

NCT07125586Not ApplicableRecruitingPrimary

Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy

NCT07107256Phase 3RecruitingPrimary

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

NCT07200336Phase 4Not Yet RecruitingPrimary

Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP

NCT07134686Not ApplicableNot Yet Recruiting

Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study).

NCT07046117Not ApplicableNot Yet Recruiting

Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps

NCT06617754Active Not RecruitingPrimary

International Severe CRSwNP Registry 2024-2028

NCT06801353Phase 4Not Yet RecruitingPrimary

A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps

NCT06683261RecruitingPrimary

Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

NCT06231004Not Yet RecruitingPrimary

Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP

NCT03956862Phase 2Completed

GB001 in Adult Participants With Chronic Rhinosinusitis

Showing all 17 trials

Research Network

Activity Timeline